You haven't justified your claim that Investors could lose the LOT.
How is this likely?
Also thanks for misrepresenting my statements:
I didn't say Sirtex was exactly comparable, I used it as an example of how disappointing clinical trials will not necessarily result in delisting of the stock and shareholders losing everything.
Also Sirtex doesn't have a wide portfolio of patents, and a platform of multiple applications like MSB does.
BUT it is your claim that investors could lose the lot, and it's a timely exaggeration.
What is the likelihood of it happening? It's your claim not mine!
Justify it.
You haven't justified your claim that Investors could lose the...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |